{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:35:59Z","timestamp":1752230159835},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,26]]},"DOI":"10.7759\/cureus.19922","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T16:41:41Z","timestamp":1637944901000},"source":"Crossref","is-referenced-by-count":2,"title":["Risk of Hepatobiliary-Gastrointestinal Malignancies and Appropriate Cancer Surveillance in Patients With Primary Sclerosing Cholangitis"],"prefix":"10.7759","author":[{"given":"Sujani","family":"Yadlapati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A","family":"Judge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-11-83","article-title":"The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population","volume":"11","author":"Toy E","year":"2011","unstructured":"Toy E, Balasubramanian S, Selmi C, Li CS, Bowlus CL. The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population. BMC Gastroenterol. 2011, 11:83. 10.1186\/1471-230X-11-83","journal-title":"BMC Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha K","year":"2003","unstructured":"Bambha K, Kim WR, Talwalkar J, et al.. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003, 125:1364-9. 10.1016\/j.gastro.2003.07.011","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22161","article-title":"Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations","volume":"16","author":"Bowlus CL","year":"2010","unstructured":"Bowlus CL, Li CS, Karlsen TH, Lie BA, Selmi C. Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations. Liver Transpl. 2010, 16:1324-30. 10.1002\/lt.22161","journal-title":"Liver Transpl"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra K","year":"2013","unstructured":"Boonstra K, Weersma RK, van Erpecum KJ, et al.. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013, 58:2045-55. 10.1002\/hep.26565","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen MM","year":"2009","unstructured":"Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol. 2009, 50:158-64. 10.1016\/j.jhep.2008.08.013","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.02.017","article-title":"Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study","volume":"48","author":"Card TR","year":"2008","unstructured":"Card TR, Solaymani-Dodaran M, West J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol. 2008, 48:939-44. 10.1016\/j.jhep.2008.02.017","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist A","year":"2002","unstructured":"Bergquist A, Ekbom A, Olsson R, et al.. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002, 36:321-7. 10.1016\/S0168-8278(01)00288-4","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.19080\/ARGH.2021.17.555954","article-title":"Cholangiocarcinoma surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis","volume":"17","author":"Sujani Y","year":"2020","unstructured":"Sujani Y, Thomas A J. Cholangiocarcinoma surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis. Adv Res Gasteroentorol Hepatol. 2020, 17:55594. 10.19080\/ARGH.2021.17.555954","journal-title":"Adv Res Gasteroentorol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0360-9","article-title":"Malignancies in inflammatory bowel disease: frequency, incidence and risk factors-results from the Swiss IBD Cohort Study","volume":"114","author":"Scharl S","year":"2019","unstructured":"Scharl S, Barthel C, Rossel JB, et al.. Malignancies in inflammatory bowel disease: frequency, incidence and risk factors-results from the Swiss IBD Cohort Study. Am J Gastroenterol. 2019, 114:116-26. 10.1038\/s41395-018-0360-9","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-009-9365-4","article-title":"Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003","volume":"24","author":"Erichsen R","year":"2009","unstructured":"Erichsen R, Jepsen P, Vilstrup H, Ekbom A, S\u00f8rensen HT. Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003. Eur J Epidemiol. 2009, 24:513-20. 10.1007\/s10654-009-9365-4","journal-title":"Eur J Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.02.016","article-title":"Primary sclerosing cholangitis: diagnosis, prognosis, and management","volume":"11","author":"Singh S","year":"2013","unstructured":"Singh S, Talwalkar JA. Primary sclerosing cholangitis: diagnosis, prognosis, and management. Clin Gastroenterol Hepatol. 2013, 11:898-907. 10.1016\/j.cgh.2013.02.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040419","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis","volume":"11","author":"Rosen CB","year":"1991","unstructured":"Rosen CB, Nagorney DM. Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis. 1991, 11:26-30. 10.1055\/s-2008-1040419","journal-title":"Semin Liver Dis"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak K","year":"2004","unstructured":"Burak K, Angulo P, Pasha TM, et al.. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2004, 99:523-6.","journal-title":"Am J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman R","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010, 51:660-78. 10.1002\/hep.23294","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.112","article-title":"ACG Clinical Guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor KD","year":"2015","unstructured":"Lindor KD, Kowdley KV, Harrison ME. ACG Clinical Guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015, 110:646-59. 10.1038\/ajg.2015.112","journal-title":"Am J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","unstructured":"EASL Clinical Practice Guidelines. management of cholestatic liver diseases. J Hepatol. 2009, 51:237-67. 10.1016\/j.jhep.2009.04.009","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya P","year":"2008","unstructured":"Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology. 2008, 48:1106-17. 10.1002\/hep.22441","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-828891","article-title":"Serum and bile markers for cholangiocarcinoma","volume":"24","author":"Nehls O","year":"2004","unstructured":"Nehls O, Gregor M, Klump B. Serum and bile markers for cholangiocarcinoma. Semin Liver Dis. 2004, 24:139-54. 10.1055\/s-2004-828891","journal-title":"Semin Liver Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2013.11.001","article-title":"Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Navaneethan U","year":"2014","unstructured":"Navaneethan U, Njei B, Venkatesh PG, Vargo JJ, Parsi MA. Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc. 2014, 79:943-950.e3. 10.1016\/j.gie.2013.11.001","journal-title":"Gastrointest Endosc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21509","article-title":"Strategies for improving diagnostic accuracy of biliary strictures","volume":"123","author":"Salomao M","year":"2015","unstructured":"Salomao M, Gonda TA, Margolskee E, et al.. Strategies for improving diagnostic accuracy of biliary strictures. Cancer Cytopathol. 2015, 123:244-52. 10.1002\/cncy.21509","journal-title":"Cancer Cytopathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-015-0438-0","article-title":"Screening for malignancy in primary sclerosing cholangitis (PSC)","volume":"17","author":"Khaderi SA","year":"2015","unstructured":"Khaderi SA, Sussman NL. Screening for malignancy in primary sclerosing cholangitis (PSC). Curr Gastroenterol Rep. 2015, 17:17. 10.1007\/s11894-015-0438-0","journal-title":"Curr Gastroenterol Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said K","year":"2008","unstructured":"Said K, Glaumann H, Bergquist A. Gallbladder disease in patients with primary sclerosing cholangitis. J Hepatol. 2008, 48:598-605. 10.1016\/j.jhep.2007.11.019","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(02)04033-9","article-title":"In primary sclerosing cholangitis, gallbladder polyps are frequently malignant","volume":"97","author":"Buckles DC","year":"2002","unstructured":"Buckles DC, Lindor KD, Larusso NF, et al.. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant. Am J Gastroenterol. 2002, 97:1138-42. 10.1016\/S0002-9270(02)04033-9","journal-title":"Am J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80356-X","article-title":"Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?","volume":"27","author":"Harnois DM","year":"1997","unstructured":"Harnois DM, Gores GJ, Ludwig J, et al.. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?. J Hepatol. 1997, 27:512-6. 10.1016\/S0168-8278(97)80356-X","journal-title":"J Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno RM","year":"2002","unstructured":"Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002, 56:48-54. 10.1067\/mge.2002.125367","journal-title":"Gastrointest Endosc"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.01.023","article-title":"High risk of advanced colorectal neoplasia in patients with primary sclerosing cholangitis associated with inflammatory bowel disease","volume":"16","author":"Shah SC","year":"2018","unstructured":"Shah SC, Ten Hove JR, Castaneda D, et al.. High risk of advanced colorectal neoplasia in patients with primary sclerosing cholangitis associated with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2018, 16:1106-1113.e3. 10.1016\/j.cgh.2018.01.023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2006.03.002","article-title":"Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study","volume":"38","author":"Viljamaa M","year":"2006","unstructured":"Viljamaa M, Kaukinen K, Pukkala E, Hervonen K, Reunala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis. 2006, 38:374-80. 10.1016\/j.dld.2006.03.002","journal-title":"Dig Liver Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery J","year":"2007","unstructured":"Fevery J, Verslype C, Lai G, Aerts R, Van Steenbergen W. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig Dis Sci. 2007, 52:3123-35. 10.1007\/s10620-006-9681-4","journal-title":"Dig Dis Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis KN","year":"2016","unstructured":"Lazaridis KN, LaRusso NF. Primary sclerosing cholangitis. N Engl J Med. 2016, 375:1161-70. 10.1056\/NEJMra1506330","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"67","author":"Ali AH","year":"2018","unstructured":"Ali AH, Tabibian JH, Nasser-Ghodsi N, et al.. Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis. Hepatology. 2018, 67:2338-51. 10.1002\/hep.29730","journal-title":"Hepatology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77571-risk-of-hepatobiliary-gastrointestinal-malignancies-and-appropriate-cancer-surveillance-in-patients-with-primary-sclerosing-cholangitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:07Z","timestamp":1707507067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77571-risk-of-hepatobiliary-gastrointestinal-malignancies-and-appropriate-cancer-surveillance-in-patients-with-primary-sclerosing-cholangitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.19922","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,26]]}}}